findmyKOL

Naim Alkhouri, MD

Enriched profile

Chief Academic Officer, Summit Clinical Research; Director, Steatotic Liver Program, Clinical Research Institute of Ohio (CRIOH) · Clinical Research Institute of Ohio (CRIOH)

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Westlake, OH · Midwest · United StatesSpecialtyGastroenterologyFocusLiver Disease Diagnosis and Treatment+4
Active KOLLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Naim Alkhouri is Chief Academic Officer, Summit Clinical Research; Director, Steatotic Liver Program, Clinical Research Institute of Ohio (CRIOH) at Clinical Research Institute of Ohio (CRIOH). OpenAlex indexes 680 publications with 21,714 citations (h-index 75); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Gastroenterology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Naim Alkhouri, MD, is Chief Academic Officer, Summit Clinical Research at Clinical Research Institute of Ohio (CRIOH), Westlake, OH. The public record shows 680 publications with 21,714 citations (h-index 75), centered on Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Liver Diseases and Immunity. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 52 companies.

  • Most recent indexed publication: 2026 · Alimentary pharmacology & therapeutics
  • Top research focus: Liver Disease Diagnosis and Treatment
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 52 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Non-alcoholic Fatty Liver Disease3 trialsFatty Liver3 trialsFatty Liver, Alcoholic3 trialsNASH / NAFLD / MASH2 trialsObesity1 trialMetabolic Syndrome1 trialViral Hepatitis (B/C)

Research focus

OpenAlex concept fingerprint
Liver Disease Diagnosis and TreatmentLiver Disease and TransplantationLiver Diseases and ImmunityHepatitis C virus researchDiet, Metabolism, and Disease

Drugs & molecules

across trials, industry payments and publications
Rezdiffrageneric · ResmetiromClinical trials—Industry payments202Publications5Ocalivageneric · Obeticholic acidClinical trials—Industry payments51Publications1Mavyretgeneric · Glecaprevir / pibrentasvirClinical trials—Industry payments83Publications—Epclusageneric · Sofosbuvir / velpatasvirClinical trials—Industry payments62Publications—Bylvaygeneric · OdevixibatClinical trials—Industry payments47Publications—Iqirvogeneric · ElafibranorClinical trials—Industry payments39Publications—Livdelzigeneric · SeladelparClinical trials—Industry payments34Publications—XIFAXANgeneric · RifaximinClinical trials—Industry payments29Publications—Lenvimageneric · LenvatinibClinical trials—Industry payments26Publications—Wegovygeneric · SemaglutideClinical trials—Industry payments22Publications—Livmarligeneric · MaralixibatClinical trials—Industry payments18Publications—PLENVUClinical trials—Industry payments8Publications—

Works with

trial sponsors and companies reporting payments
Madrigal PharmaceuticalsClinical trials—Industry payments213Gilead Sciences, Inc.Clinical trials—Industry payments155Abbvie Inc.Clinical trials—Industry payments96Novo Nordisk IncClinical trials—Industry payments81Ipsen Biopharmaceuticals, IncClinical trials—Industry payments73Intercept Pharmaceuticals, Inc.Clinical trials—Industry payments51Boehringer Ingelheim International GmbHClinical trials—Industry payments46Perspectum Diagnostics LtdClinical trials—Industry payments36Salix Pharmaceuticals, a division of Bausch Health US, LLCClinical trials—Industry payments30Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments28Echosens North America, Inc.Clinical trials—Industry payments28Merck Sharp & Dohme LLCClinical trials—Industry payments26Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments23Eisai Inc.Clinical trials—Industry payments23Mirum Pharmaceuticals, Inc.Clinical trials—Industry payments18Albireo Pharma, Inc.Clinical trials—Industry payments16Novo Nordisk ASClinical trials—Industry payments11Siemens Medical Solutions USA, Inc.Clinical trials—Industry payments8Travere Therapeutics, Inc.Clinical trials—Industry payments7Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments6Pfizer Inc.Clinical trials—Industry payments5Boston Scientific CorporationClinical trials—Industry payments4Cook Medical LLCClinical trials—Industry payments4GlaxoSmithKline, LLC.Clinical trials—Industry payments4Theratechnologies Inc.Clinical trials—Industry payments4W. L. Gore & Associates, Inc.Clinical trials—Industry payments4Intra-Sana LaboratoriesClinical trials—Industry payments3Janssen Biotech, Inc.Clinical trials—Industry payments3Merck Sharp & Dohme CorporationClinical trials—Industry payments3Orphalan IncClinical trials—Industry payments3

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
680publications

Distinct works indexed by OpenAlex, matched via ORCID; 24 in PubMed.

21,714citations

Total citations across indexed works.

75h-index

Hirsch index (OpenAlex). i10-index 220.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
52companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

52 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    51%
    Bile Acid15.3%
    Ursodiol100%
    Part D≥43 patients
    Rifamycin Antibacterial10.6%
    Xifaxan100%
    Part D≥26 patients

    + 8 more classes in this area

  • Cardiovascular

    32.3%
    Aldosterone antagonist (MRA)12.1%
    Spironolactone100%
    Part D≥48 patients
    Loop diuretic10.8%
    Furosemide100%
    Part D≥39 patients

    + 3 more classes in this area

  • Anti-infectives

    11.3%
    Nucleoside and nucleotide reverse transcriptase inhibitors8.5%
    Vemlidy76%Tenofovir Disoproxil Fumarate24%
    Part D<11 patients
    Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor2.9%
    Epclusa100%
    Part D≥13 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 14 Oct 2026

8 congress contributions (2016–2025) across ADA, ASCO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Rocío López150Mazen Noureddin143Stephen A. Harrison81Nizar N. Zein65Ariel E. Feldstein61Eric Lawitz59Rohit Loomba57Jörn M. Schattenberg54Ibrahim A. Hanouneh51Vincent Wai‐Sun Wong37Valério Nobili33Zobair M. Younossi31Anita Kohli30Quentin M. Anstee30Guy Neff30Manal F. Abdelmalek29Raed A. Dweik29David Grove27Michael Charlton27Amandeep Singh26Mohammad Nasser Kabbany25Praveen Kumar Conjeevaram Selvakumar25Kris V. Kowdley24Fred Poordad23Arun J. Sanyal23Julie Dubourg23Rebecca Taub22Bijan Eghtesad21Mary E. Rinella20Vlad Ratziu20Lisa Yerian20Phuc Le20Zachary Goodman19Nabil Noureddin18Arthur J. McCullough18Vlad Ratziu18Winston Dunn17Marco Arrese17Pierre Bédossa16Juan Pablo Arab16

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/alkhouri-naim-20552049

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • LinkedIn

    linkedin.com/in/naim-alkhouri-md-faasld-3b13074b

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/profile/Naim-Alkhouri

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • Doximity

    doximity.com/pub/naim-alkhouri-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/reel/C6NFLJtv4CX

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
  • Other

    my.clevelandclinic.org/staff/109703-naim-alkhouri

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →my.clevelandclinic.org ↗
  • Apple Podcasts

    podcasts.apple.com/de/podcast/naim-alkhouri-md-faasld-dabom-dont-wait-and-look/id718222632

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
  • Other

    aasld.org/tlm-26/naim-alkhouri

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • LinkedIn

    LinkedIn profile (Chief Academic Officer, Summit Clinical Research)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Fellowship

    Acute and Chronic Liver Disease (Transplant Hepatology), Cleveland Clinic

    2011
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →my.clevelandclinic.org ↗
  • Fellowship

    Pediatric Gastroenterology, Cleveland Clinic

    2010
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →my.clevelandclinic.org ↗
  • Residency

    Internal Medicine/Pediatrics, Albert Einstein Medical Center, Philadelphia

    2007
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →my.clevelandclinic.org ↗
  • MD

    Damascus University Faculty of Medicine

    2001
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →my.clevelandclinic.org ↗
  • Board Certified

    Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →my.clevelandclinic.org ↗
  • Board Certified

    Obesity Medicine (DABOM, Diplomate American Board of Obesity Medicine)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohioresearch.com ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohioresearch.com ↗

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Former Chief Medical Officer

    Chief of Transplant Hepatology, and Director of the Steatotic Liver Program, Arizona Liver Health, Phoenix, AZ

    2025
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com ↗
  • Staff physician

    Cleveland Clinic Community Hospital / Avon Hospital, Regional Operations (secondary/legacy listing)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →my.clevelandclinic.org ↗
  • Former Director

    Metabolic Health Center, Texas Liver Institute; former Associate Professor of Medicine and Pediatrics, University of Texas Health Science Center at San Antonio

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com ↗
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nash.gastro.org ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.